Tvardi Therapeutics
Dan Conn, J.D., M.B.A. is a seasoned executive with an extensive background in corporate law, finance, and business management. Mr. Conn began his career as an M&A and securities lawyer before moving to investment banking. As a banker, he was an Executive Director at Morgan Stanley and a Director at PJ Solomon, focusing on M&A, restructuring, and financing transactions in the life sciences and other industries. Mr. Conn transitioned to the buy side, investing in multiple industries including life sciences, as a Vice President and Portfolio Manager at DE Shaw & Co and then Senior Vice President and Portfolio Manager at Brookfield Asset Management. Most recently, Mr. Conn’s focus became more operational, directing the development and monetization of intellectual property rights. Mr. Conn holds a BA and JD from the University of Toronto and an MBA from the Anderson School of Business at UCLA, where he was an International Management Fellow.
This person is not in any teams
This person is not in any offices
Tvardi Therapeutics
1 followers
Tvardi Therapeutics is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. Founded in 2017 and based in Houston, Texas, the company is led by experienced entrepreneurs, innovative scientists and dedicated physicians.